Published in Patient Saf Surg on April 25, 2008
Extending the limitations of liver surgery: outcomes of initial human experience in a high-volume center performing single-port laparoscopic liver resection for hepatocellular carcinoma. Surg Endosc (2011) 1.00
Oral glucose tolerance test for preoperative assessment of liver function in liver resection. Ann Hepatobiliary Pancreat Surg (2017) 0.75
Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg (2004) 55.13
Nonalcoholic fatty liver disease. N Engl J Med (2002) 22.41
Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol (1999) 14.07
Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg (2002) 8.30
Obesity in general elective surgery. Lancet (2003) 7.22
Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology (2005) 7.03
The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology (1990) 6.53
Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg (2001) 5.94
Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg (2000) 5.79
Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology (1999) 5.70
The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology (2002) 5.70
Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg (1999) 4.97
Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol (2007) 4.95
Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med (2000) 4.92
AGA technical review on nonalcoholic fatty liver disease. Gastroenterology (2002) 4.61
The epidemiology of wound infection. A 10-year prospective study of 62,939 wounds. Surg Clin North Am (1980) 4.31
An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg (1999) 4.26
A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology (1990) 4.02
Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery (1990) 3.93
Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology (1990) 3.63
The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg (2005) 3.46
Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg (2003) 3.16
Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg (2003) 3.14
Strategies for safer liver surgery and partial liver transplantation. N Engl J Med (2007) 3.14
Platelet-derived serotonin mediates liver regeneration. Science (2006) 2.98
Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology (1996) 2.96
Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg (1999) 2.86
Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann Surg (1999) 2.68
Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Transpl (2001) 2.66
Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann Surg (2006) 2.59
A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg (2003) 2.48
No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg (1999) 2.47
Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg (1995) 2.37
Protective strategies against ischemic injury of the liver. Gastroenterology (2003) 2.37
Randomized comparison of ultrasonic vs clamp transection of the liver. Arch Surg (2001) 2.25
How should transection of the liver be performed?: a prospective randomized study in 100 consecutive patients: comparing four different transection strategies. Ann Surg (2005) 2.16
Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg (2000) 2.16
Laparoscopic liver resection for peripheral hepatocellular carcinoma in patients with chronic liver disease: midterm results and perspectives. Ann Surg (2006) 2.10
Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transplant (2005) 2.06
Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg (2003) 2.05
Drainage is unnecessary after elective liver resection. Am J Surg (1996) 2.03
Splenectomy in patients with hepatocellular carcinoma and hypersplenism. J Am Coll Surg (2000) 1.99
Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet (1987) 1.98
Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg (1999) 1.94
Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer (2001) 1.94
Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg (2003) 1.88
Fatty liver in liver transplantation and surgery. Semin Liver Dis (2001) 1.79
Abdominal drainage after hepatic resection is contraindicated in patients with chronic liver diseases. Ann Surg (2004) 1.79
Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord (1998) 1.76
Preoperative assessment of liver function. Surg Clin North Am (2004) 1.67
Drainage after elective hepatic resection. A randomized trial. Ann Surg (1993) 1.59
Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg (2006) 1.57
Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn J Med (1988) 1.54
Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality. J Gastrointest Surg (2005) 1.52
Steatosis as a risk factor in liver surgery. Ann Surg (2007) 1.48
Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Ann Surg (2002) 1.45
Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study. Ann Surg (2007) 1.42
A prospective, randomized, controlled trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection. Ann Surg (2006) 1.39
Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test. Br J Surg (1999) 1.22
Preoperative biliary drainage for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg (2007) 1.20
Preoperative galactose elimination capacity predicts complications and survival after hepatic resection. Ann Surg (2002) 1.16
Estimation of risk of major complications after hepatic resection. Am J Surg (1994) 1.16
Does diabetes mellitus influence the perioperative outcome or long term prognosis after resection of hepatocellular carcinoma? Am J Gastroenterol (2002) 1.16
Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer. J Gastrointest Surg (2002) 1.15
Hepatic resection of hepatocellular carcinoma in cirrhotic livers: is it unjustified in impaired liver function? Surgery (1996) 1.11
Frozen section evaluation of donor livers before transplantation. Transplantation (1993) 1.10
Laparoscopic liver resection. Br J Surg (2003) 1.09
A comparative study of postoperative complications after hepatectomy in patients with and without chronic liver disease. Surgery (1999) 1.07
Liver morphology in morbid obesity: a literature study. Int J Obes (1984) 1.06
Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long-term survival and tumour recurrence in a single centre. Aliment Pharmacol Ther (2003) 1.05
Surgical therapy of hepatocellular carcinoma. Eur J Gastroenterol Hepatol (2005) 1.04
Hepatic steatosis in liver transplant donors: common feature of donor population? World J Surg (1998) 1.01
Portal vein embolization with N-butyl cyanoacrylate before partial hepatectomy in patients with hepatocellular carcinoma and underlying cirrhosis or advanced fibrosis. J Vasc Interv Radiol (2005) 1.00
Functional hepatic volume measured by technetium-99m-galactosyl-human serum albumin liver scintigraphy: comparison between hepatocyte volume and liver volume by computed tomography. Am J Gastroenterol (2001) 0.95
Assessment of hepatic reserve for indication of hepatic resection: how I do it. J Hepatobiliary Pancreat Surg (2005) 0.93
Retrospective analysis of type of hepatic resection for hepatocellular carcinoma. Br J Surg (2000) 0.91
ICG pulse spectrophotometry for perioperative liver function in hepatectomy. J Surg Res (2002) 0.90
Peri-operative mortality in hepatic resection. Aust N Z J Surg (1991) 0.89
Quantitative testing of liver function in patients with cirrhosis due to chronic hepatitis C to assess disease severity. Liver (2001) 0.88
Body fat accumulation and postoperative complications after abdominal surgery. Am Surg (2004) 0.87
Liver surgery in the era of tissue-preserving resections: early and late outcome in patients with primary and secondary hepatic tumors. World J Surg (2002) 0.85
Improving operative safety for cirrhotic liver resection. Br J Surg (2001) 0.83
The hippurate ratio as an indicator of functional hepatic reserve for resection of hepatocellular carcinoma in cirrhotic patients. J Gastrointest Surg (2001) 0.82
Continuous versus intermittent portal triad clamping during hepatectomy in cirrhosis. Results of a prospective, randomized clinical trial. Hepatogastroenterology (2003) 0.81
Segment VIII resection of the cirrhotic liver under continuous pringle maneuver with in situ cooling followed by temporary portal decompression. Am J Surg (1999) 0.80
Appraisal of concomitant splenectomy in liver resection for hepatocellular carcinoma in cirrhotic patients with hypersplenic thrombocytopenia. Surgery (2004) 0.80
A critical evaluation of hepatic resection in cirrhosis: optimizing patient selection and outcomes. World J Surg (2005) 0.79
[Laparoscopic liver resection without a Pringle maneuver for HCC in cirrhotic patients]. Chir Ital (2005) 0.79
Do we need a center approach to treat patients with liver diseases? J Hepatol (2006) 0.76
Acta Gastroenterol Latinoam (2017) 1.92
Acute liver failure due to concomitant arterial, portal and biliary injury during laparoscopic cholecystectomy: is transplantation a valid life-saving strategy? A case report. Patient Saf Surg (2009) 0.86
[Liver transplantation during pregnancy in a patient with acute liver failure]. Acta Gastroenterol Latinoam (2010) 0.83
Experience using liver transplantation for the treatment of severe bile duct injuries over 20 years in Argentina: results from a National Survey. HPB (Oxford) (2011) 0.83
Model for end-stage liver disease exceptions committee activity in Argentina: does it provide justice and equity among adult patients waiting for a liver transplant? HPB (Oxford) (2010) 0.79
Rescue policy for discarded liver grafts: a single-centre experience of transplanting livers 'that nobody wants'. HPB (Oxford) (2010) 0.78
[Cost analysis of liver transplantation in a community hospital: association with the Model for End-stage Liver Disease, a prognostic index to prioritize the most severe patients]. Gastroenterol Hepatol (2012) 0.76
[Laparoscopic treatment of common bile duct lithiasis associated with gallbladder lithiasis]. Cir Esp (2008) 0.76
[Efficacy of the association of a single dose of hepatitis B hyperimmune gammaglobulin and entecavir in the prophylaxis of hepatitis B after liver transplantation: experience of a single center in Argentina]. Acta Gastroenterol Latinoam (2013) 0.76
[Percutaneous management of benign pathology of the main biliary tract: experience in a section of pancreatic and hepatobiliary surgery]. Acta Gastroenterol Latinoam (2004) 0.75
[Liver trasplantation for the treatment of non-resectable metastases of neuroendocrine tumors: first report in Argentina]. Acta Gastroenterol Latinoam (2011) 0.75
[Complications of hepatic resection surgery: a 12-month experience in a high case-load specialized center]. Acta Gastroenterol Latinoam (2004) 0.75
Is it safe to use a liver graft from a Chagas disease-seropositive donor in a human immunodeficiency virus-positive recipient? A case report addressing a novel challenge in liver transplantation. Liver Transpl (2012) 0.75